Angel Matthew 4
4 · Eterna Therapeutics Inc. · Filed Jan 13, 2023
Insider Transaction Report
Form 4
Angel Matthew
DirectorInterim President and CEO
Transactions
- Award
Stock Option (right to buy)
2023-01-12+132,003→ 132,003 totalExercise: $4.84Exp: 2033-01-12→ Common Stock, par value $0.005 per share (132,003 underlying)
Footnotes (1)
- [F1]The stock options vests and becomes exercisable over three years (subject to continued service), with 110,043 of the shares vesting on the grant date, and the remaining shares vesting in 36 substantially equal monthly tranches on the first day of each month thereafter.